|
EEF1D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.858000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.795600E-02 |
| Normal-vs-Stage2 |
4.118600E-01 |
| Normal-vs-Stage3 |
2.019800E-01 |
| Normal-vs-Stage4 |
5.997900E-02 |
| Stage1-vs-Stage2 |
3.717800E-01 |
| Stage1-vs-Stage3 |
9.245000E-01 |
| Stage1-vs-Stage4 |
7.739400E-01 |
| Stage2-vs-Stage3 |
5.150800E-01 |
| Stage2-vs-Stage4 |
3.208600E-01 |
| Stage3-vs-Stage4 |
8.093200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.338060E-02 |
| Normal-vs-AfricanAmerican |
2.866400E-01 |
| Normal-vs-Asian |
8.838400E-01 |
| Caucasian-vs-AfricanAmerican |
4.250400E-01 |
| Caucasian-vs-Asian |
3.884600E-01 |
| AfricanAmerican-vs-Asian |
6.342200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.375700E-02 |
| Normal-vs-Female |
3.539600E-02 |
| Male-vs-Female |
3.385000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.086200E-01 |
| Normal-vs-Extreme_Weight |
1.202390E-03 |
| Normal-vs-Obese |
1.238250E-02 |
| Normal-vs-Extreme_Obese |
4.582800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.222400E-01 |
| Normal_Weight-vs-Obese |
2.179200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.161200E-01 |
| Extreme_Weight-vs-Obese |
9.410600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.427600E-02 |
| Obese-vs-Extreme_Obese |
1.769830E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.380370E-02 |
| Normal-vs-Age(41-60Yrs) |
1.390370E-01 |
| Normal-vs-Age(61-80Yrs) |
4.649500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.931800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.749550E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.098500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.492200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.567200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.503600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.974400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.956200E-02 |
| Normal-VS-Type2 PRCC |
4.411600E-01 |
| Normal-VS-KIRP CIMP |
3.209700E-02 |
| Normal-VS-Unclassified PRCC |
1.470750E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.562000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.349700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.500800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.166100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.990000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.642590E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.100780E-01 |
| Normal-vs-N1 |
8.662100E-02 |
| Normal-vs-N2 |
1.410550E-04 |
| N0-vs-N1 |
7.099000E-01 |
| N0-vs-N2 |
6.212400E-02 |
| N1-vs-N2 |
7.707900E-02 |
|
|
